Toll Free: 1-888-928-9744
Published: Sep, 2016 | Pages:
34 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Medestea Research & Production S.p.A. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Medestea Research & Production S.p.A. - Product Pipeline Review - 2016', provides an overview of the Medestea Research & Production S.p.A.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Medestea Research & Production S.p.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Medestea Research & Production S.p.A. - The report provides overview of Medestea Research & Production S.p.A. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Medestea Research & Production S.p.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Medestea Research & Production S.p.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons To Buy - Evaluate Medestea Research & Production S.p.A.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Medestea Research & Production S.p.A. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Medestea Research & Production S.p.A.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Medestea Research & Production S.p.A. Snapshot 5 Medestea Research & Production S.p.A. Overview 5 Key Facts 5 Medestea Research & Production S.p.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Medestea Research & Production S.p.A. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Medestea Research & Production S.p.A. - Pipeline Products Glance 12 Medestea Research & Production S.p.A. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Medestea Research & Production S.p.A. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Discovery Products/Combination Treatment Modalities 15 Medestea Research & Production S.p.A. - Drug Profiles 16 AT-20 - Drug Profile 16 Product Description 16 Mechanism Of Action 16 R&D Progress 16 Deina - Drug Profile 17 Product Description 17 Mechanism Of Action 17 R&D Progress 17 doxorubicin - Drug Profile 18 Product Description 18 Mechanism Of Action 18 R&D Progress 18 IAC-VITA - Drug Profile 19 Product Description 19 Mechanism Of Action 19 R&D Progress 19 Lysine Acetylsalicylate - Drug Profile 21 Product Description 21 Mechanism Of Action 21 R&D Progress 21 MED-1101 - Drug Profile 22 Product Description 22 Mechanism Of Action 22 R&D Progress 22 Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS - Drug Profile 23 Product Description 23 Mechanism Of Action 23 R&D Progress 23 Stem Cell Therapy for Acute Myocardial Infarction - Drug Profile 24 Product Description 24 Mechanism Of Action 24 R&D Progress 24 Tribarcina - Drug Profile 25 Product Description 25 Mechanism Of Action 25 R&D Progress 25 U-94 - Drug Profile 26 Product Description 26 Mechanism Of Action 26 R&D Progress 26 Medestea Research & Production S.p.A. - Pipeline Analysis 27 Medestea Research & Production S.p.A. - Pipeline Products by Target 27 Medestea Research & Production S.p.A. - Pipeline Products by Route of Administration 28 Medestea Research & Production S.p.A. - Pipeline Products by Molecule Type 29 Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action 30 Medestea Research & Production S.p.A. - Dormant Projects 31 Medestea Research & Production S.p.A. - Locations And Subsidiaries 32 Head Office 32 Other Locations & Subsidiaries 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34
List of Tables Medestea Research & Production S.p.A., Key Facts 5 Medestea Research & Production S.p.A. - Pipeline by Indication, 2016 8 Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2016 10 Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2016 11 Medestea Research & Production S.p.A. - Phase II, 2016 12 Medestea Research & Production S.p.A. - Phase I, 2016 13 Medestea Research & Production S.p.A. - Preclinical, 2016 14 Medestea Research & Production S.p.A. - Discovery, 2016 15 Medestea Research & Production S.p.A. - Pipeline by Target, 2016 27 Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2016 28 Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2016 29 Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2016 30 Medestea Research & Production S.p.A. - Dormant Developmental Projects,2016 31 Medestea Research & Production S.p.A., Other Locations 32
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.